한글목차

세계 트랜스펙션 시약 및 장비 시장의 잠재력은 학계, 연구기관 및 제약 및 생명공학 기업 시장에서의 기회로 인해 유망한 시장으로 평가받고 있습니다. 전 세계 트랜스펙션 시약 및 장비 시장은 2025년부터 2031년까지 6.5%의 연평균 복합 성장률(CAGR)로 2031년 약 21억 달러에 달할 것으로 예측됩니다. 이 시장의 주요 촉진요인은 전 세계적으로 만성 질환의 부담이 증가하고, 합성 유전자에 대한 높은 수요와 기술 발전으로 인해 이 시장이 성장할 것으로 예측됩니다.

• Lucintel의 예측에 따르면, 제품별로는 주요 기업들이 시약 포트폴리오를 확장하기 위해 많은 제품을 출시하고 있기 때문에 시약은 예측 기간 동안 높은 성장을 보일 것으로 예측됩니다.
• 최종 용도별로는 전 세계 질병 부담 증가와 시약 및 기기의 채택 증가로 인해 제약 및 생명공학 기업들이 가장 큰 부문을 차지할 것으로 보입니다.
• 지역별로는 유전체 연구개발에 대한 투자 증가, 단백질 치료제에 대한 수요 증가, 이 지역의 주요 기업들의 존재로 인해 북미가 예측 기간 동안 가장 큰 시장으로 남을 것으로 보입니다.

트랜스펙션 시약 및 장비 시장의 전략적 성장 기회

트랜스펙션 시약 및 장비 시장에는 몇 가지 전략적 성장 기회가 존재합니다.

• 유전자 치료: 유전자 치료에서 유전자 전달 기술의 활용이 확대됨에 따라 치료용 유전자 전달이 강화되고 치료 결과가 향상되어 큰 성장 기회를 가져다 줄 수 있습니다.
• 신약개발: 유전자 기능 및 약물 상호작용에 대한 신속한 연구가 가능해져 신약 개발이 가속화됩니다.
• 암 연구: 유전자 도입 방법의 강화는 암 연구에 필수적이며, 암 관련 유전자 및 치료 표적에 대한 연구를 향상시킵니다.
• 재생의료: 이식 기술은 재생의료의 새로운 치료법 개발에 필수적이며, 조직공학 및 줄기세포 연구의 발전에 기여하고 있습니다.
• 농업생명공학: 농업생명공학에서 트랜스펙션 기술의 가능성은 매우 크며, 식품의 안전성과 농업 생산성 향상을 위한 유전자변형 작물 개발에 기여하고 있습니다.

이러한 성장 기회는 다양한 분야에서 트랜스펙션 기술의 적용을 확대하여 시장 성장과 기술 혁신을 촉진하고 있습니다.

트랜스펙션 시약 및 장비 시장 성장 촉진요인 및 과제

트랜스펙션 시약 및 장비 시장에 영향을 미치는 다양한 요인으로는 기술, 경제, 규제 등이 있습니다. 다음은 주요 촉진요인과 과제에 대한 분석이다:

트랜스펙션 시약 및 장비 시장 성장 촉진요인으로는 다음과 같은 것들이 있습니다.

• 기술 발전: 나노입자, 자동화 등의 기술 혁신은 유전자 도입을 개선하고, 효율성과 효과의 향상을 통해 시장 성장을 가속합니다.
• 연구 투자 증가: 생명공학 및 유전체 연구에 대한 투자 증가는 첨단 트랜스펙션 기술에 대한 수요를 증가시켜 시장 확대로 이어질 것입니다.
• 유전자 치료에 대한 수요 증가: 유전자 치료의 적용 확대에 따라 효과적인 유전자 전달 기술에 대한 수요가 증가하고 있으며, 이는 시장 성장을 가속하는 요인으로 작용하고 있습니다.
• 맞춤형 의료: 맞춤형 의료의 발전으로 환자 개개인에 맞는 트랜스펙션 기술이 필요해지면서 맞춤형 솔루션에 대한 수요가 더욱 증가하고 있습니다.

트랜스펙션 시약 및 장비 시장의 과제는 다음과 같습니다.

• 높은 비용: 특히 개발도상국의 소규모 연구시설에서는 고도의 트랜스펙션 시약 및 장비의 비용으로 인해 사용을 저해할 수 있습니다.
• 기술의 복잡성: 새로운 트랜스펙션 기술의 고도화로 인해 사용자 교육 및 기존 워크플로우에 통합하는 데 어려움이 발생할 수 있습니다.

이러한 시장 성장 촉진요인과 과제는 트랜스펙션 시약 및 장비 시장을 형성하고 업계의 성장 패턴과 전략적 의사 결정에 영향을 미치고 있습니다.

목차

제1장 주요 요약

제2장 세계의 트랜스펙션 시약 및 장비 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019년-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 트랜스펙션 시약 및 장비 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 트랜스펙션 시약 및 장비 시장 : 제품별
  • 시약
  • 장비
• 세계의 트랜스펙션 시약 및 장비 시장 : 방법별
  • 물리적 방법
  • 생화학적 방법
  • 바이러스에 의한 방법
• 세계의 트랜스펙션 시약 및 장비 시장 : 용도별
  • 단백질 생산
  • 생물의학 연구
  • 치료 제공
• 세계의 트랜스펙션 시약 및 장비 시장 : 최종 용도별
  • 학술기관 및 연구기관
  • 제약 기업 및 바이오테크놀러지 기업
  • 기타

제4장 지역별 시장 동향과 예측 분석(2019년-2031년)

• 세계의 트랜스펙션 시약 및 장비 시장 : 지역별
• 북미의 트랜스펙션 시약 및 장비 시장
• 유럽의 트랜스펙션 시약 및 장비 시장
• 아시아태평양의 트랜스펙션 시약 및 장비 시장
• 기타 지역의 트랜스펙션 시약 및 장비 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 트랜스펙션 시약 및 장비 시장 성장 기회 : 제품별
  • 세계의 트랜스펙션 시약 및 장비 시장 성장 기회 : 방법별
  • 세계의 트랜스펙션 시약 및 장비 시장 성장 기회 : 용도별
  • 세계의 트랜스펙션 시약 및 장비 시장 성장 기회 : 최종 용도별
  • 세계의 트랜스펙션 시약 및 장비 시장 성장 기회 : 지역별
• 세계 트랜스펙션 시약 및 장비 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 트랜스펙션 시약 및 장비 시장 생산능력 확대
  • 세계 트랜스펙션 시약 및 장비 시장에서의 인수합병(M&A) 및 합작투자(JV)
  • 인증 및 라이선싱

제7장 주요 기업 개요

• PromoCell
• OriGene Technologies
• Thermos Fisher Scientific
• Merck
• Bio-Rad Laboratories
• Lonza
• Qiagen N.V.
• Mirus Bio
• Promega Corporation
• F. Hoffmann-La Roche

영문목차

The future of the global transfection reagent and equipment market looks promising with opportunities in the academic & research institute and pharmaceutical & biotechnology company markets. The global transfection reagent and equipment market is expected to reach an estimated $2.1 billion by 2031 with a CAGR of 6.5% from 2025 to 2031. The major drivers for this market are the increasing burden of chronic diseases across the globe, high demand for synthetic genes, and technological advancements in transfection.

• Lucintel forecasts that, within the product category, the reagent is expected to witness higher growth over the forecast period due to a huge number of launches by key players to broaden their reagents portfolio.
• Within the end use category, pharmaceutical & biotechnology companies will remain the largest segment due to increasing burden of diseases and rising adoption of reagent and equipment worldwide.
• In terms of regions, North America will remain the largest segment over the forecast period due to rising investments in research and development in genomics, growing demand for protein therapeutics, and the existence of major players in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Transfection Reagent and Equipment Market

The transfection reagents and equipment market is evolving with several notable trends:

• Nanoparticle-Based Reagents: These reagents are becoming popular due to their effectiveness in gene delivery with minimal cytotoxicity. Their superior stability and targeting capabilities lead to higher success rates in transfection.
• Transfection Automation: Automation technologies facilitate high-throughput screening, reducing manual intervention. Automated systems enhance reproducibility and efficiency, supporting extensive research and therapeutic applications.
• Advanced Electroporation Systems: New developments in electroporation technology improve the precision and efficiency of gene delivery, enhancing the intracellular delivery of nucleic acids for gene therapy and genetic research.
• Integration with Gene Editing Tools: The merging of transfection technologies with tools like CRISPR/Cas9 is gaining traction, increasing the efficiency and specificity of genetic modifications.
• Applications in Personalized Medicine: Transfection technologies are increasingly tailored to individual genetic backgrounds, enhancing their effectiveness in gene therapies and targeted treatments.

These trends are driving innovation and expanding the applications of transfection reagents and equipment, thereby improving research and therapeutic development prospects.

Recent Developments in the Transfection Reagent and Equipment Market

Key developments in the transfection reagent and equipment market include:

• Nanoparticle Innovations: Advanced nanoparticle-based transfection reagents are enhancing gene delivery efficiency while reducing cytotoxicity, making them suitable for diverse research and therapeutic applications.
• High-Throughput Systems: The introduction of high-throughput transfection systems is streamlining workflows and increasing productivity in genomic research by enabling simultaneous processing of multiple samples.
• Cost-Effective Solutions: The design of novel, affordable reagents and equipment is making advanced transfection technologies more accessible, especially in developing regions, thus enhancing global research and development.
• Electroporation Technologies: New electroporation systems offer improved control over gene delivery accuracy and efficiency, expanding applications in gene therapy and cellular research.
• Integration with Advanced Technologies: The latest transfection technologies are increasingly integrated with advanced tools like CRISPR/Cas9, facilitating precise genetic alterations and innovative therapeutic approaches.

These developments are propelling the field towards more efficient, accessible, and precise applications.

Strategic Growth Opportunities for Transfection Reagent and Equipment Market

Several strategic growth opportunities exist within the transfection reagent and equipment market:

• Gene Therapy: The growing use of transfection technologies in gene therapy presents significant growth opportunities, enhancing the delivery of therapeutic genes and improving treatment outcomes.
• Drug Discovery: Transfection technologies are becoming essential in drug discovery processes, enabling rapid studies of gene function and drug interactions, thus accelerating new drug development.
• Cancer Research: Enhanced methodologies for gene delivery are crucial for cancer research, improving the study of cancer-related genes and therapeutic targets.
• Regenerative Medicine: Transfection technologies are vital in developing new treatments within regenerative medicine, contributing to advancements in tissue engineering and stem cell research.
• Agricultural Biotechnology: There is significant potential for transfection technologies in agricultural biotechnology, aiding in the development of genetically modified crops for enhanced food safety and agricultural productivity.

These growth opportunities are expanding the application of transfection technologies across various sectors, driving market growth and innovation.

Transfection Reagent and Equipment Market Driver and Challenges

The various factors affecting the transfection reagent and equipment market include technological, economic, and regulatory. Below is an analysis of major drivers and challenges:

The factors responsible for driving the transfection reagent and equipment market include:

• Technological Advancements: Innovations like nanoparticles and automation improve gene delivery, driving market growth through enhanced efficiency and effectiveness.
• Increased Research Investments: Growing investments in biotechnology and genomic research are boosting demand for advanced transfection technologies, leading to market expansion.
• Rising Demand for Gene Therapies: The expanding applications of gene therapy create a heightened need for effective transfection technologies, catalyzing market growth.
• Personalized Medicine: The advancement of personalized medicine necessitates tailored transfection techniques, further driving demand for customized solutions.

Challenges in the transfection reagent and equipment market are:

• High Costs: The expense of sophisticated transfection reagents and equipment can deter use, particularly in smaller research facilities in developing regions.
• Complexity of Technologies: The sophistication of new transfection technologies can present challenges in user training and integration into existing workflows.

These drivers and challenges shape the transfection reagent and equipment market, influencing growth patterns and strategic decisions within the industry.

List of Transfection Reagent and Equipment Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies transfection reagents and equipment companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the transfection reagent and equipment companies profiled in this report include-

• PromoCell
• OriGene Technologies
• Thermos Fisher Scientific
• Merck
• Bio-Rad Laboratories
• Lonza
• Qiagen N.V.
• Mirus Bio
• Promega Corporation
• F. Hoffmann-La Roche

Transfection Reagent and Equipment by Segment

The study includes a forecast for the global transfection reagent and equipment market by product, method, application, end use, and region.

Transfection Reagent and Equipment Market by Product [Analysis by Value from 2019 to 2031]:

• Reagents
• Equipment

Transfection Reagent and Equipment Market by Method [Analysis by Value from 2019 to 2031]:

• Physical Methods
• Biochemical Methods
• Viral Methods

Transfection Reagent and Equipment Market by Application [Analysis by Value from 2019 to 2031]:

• Protein Production
• Biomedical Research
• Therapeutic Delivery

Transfection Reagent and Equipment Market by End Use [Analysis by Value from 2019 to 2031]:

• Academics & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Others

Transfection Reagent and Equipment Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Transfection Reagent and Equipment Market

The transfection reagents and equipment market is rapidly evolving, driven by continuous technological advancements and expanding applications in research and therapeutics. Recent developments in key markets include:

• United States: The U.S. market is experiencing significant growth due to advancements in nanoparticle-based transfection reagents and electroporation equipment, improving gene delivery efficiency for research and therapeutic applications.
• China: Increased domestic production of affordable reagents and equipment is fostering growth in China, enhancing accessibility for local researchers and biotech firms.
• Germany: Ongoing development of high-throughput transfection systems and reagents in Germany is improving workflow efficiency in genomic research and pharmaceutical development.
• India: Investment in biotechnology research and development is driving growth in transfection technologies, with initiatives focused on creating affordable and scalable solutions.
• Japan: Japan is prioritizing the integration of microfluidics and gene editing tools in transfection systems, enhancing precision and efficiency in gene delivery for various applications.

Features of the Global Transfection Reagent and Equipment Market

Market Size Estimates: Transfection reagent and equipment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Transfection reagent and equipment market size by various segments, such as by product, method, application, end use, and region in terms of value ($B).

Regional Analysis: Transfection reagent and equipment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, methods, applications, end uses, and regions for the transfection reagent and equipment market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the transfection reagent and equipment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M&A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the transfection reagent and equipment market by product (reagents and equipment), method (physical methods, biochemical methods, and viral methods), application (protein production, biomedical research, and therapeutic delivery), end use (academics & research institutes, pharmaceutical & biotechnology companies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Transfection Reagent and Equipment Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Transfection Reagent and Equipment Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Transfection Reagent and Equipment Market by Product
  • 3.3.1: Reagents
  • 3.3.2: Equipment
• 3.4: Global Transfection Reagent and Equipment Market by Method
  • 3.4.1: Physical Methods
  • 3.4.2: Biochemical Methods
  • 3.4.3: Viral Methods
• 3.5: Global Transfection Reagent and Equipment Market by Application
  • 3.5.1: Protein Production
  • 3.5.2: Biomedical Research
  • 3.5.3: Therapeutic Delivery
• 3.6: Global Transfection Reagent and Equipment Market by End Use
  • 3.6.1: Academics & Research Institutes
  • 3.6.2: Pharmaceutical & Biotechnology Companies
  • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Transfection Reagent and Equipment Market by Region
• 4.2: North American Transfection Reagent and Equipment Market
  • 4.2.1: North American Market by Product: Reagents and Equipment
  • 4.2.2: North American Market by End Use: Academics & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others
• 4.3: European Transfection Reagent and Equipment Market
  • 4.3.1: European Market by Product: Reagents and Equipment
  • 4.3.2: European Market by End Use: Academics & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others
• 4.4: APAC Transfection Reagent and Equipment Market
  • 4.4.1: APAC Market by Product: Reagents and Equipment
  • 4.4.2: APAC Market by End Use: Academics & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others
• 4.5: ROW Transfection Reagent and Equipment Market
  • 4.5.1: ROW Market by Product: Reagents and Equipment
  • 4.5.2: ROW Market by End Use: Academics & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Transfection Reagent and Equipment Market by Product
  • 6.1.2: Growth Opportunities for the Global Transfection Reagent and Equipment Market by Method
  • 6.1.3: Growth Opportunities for the Global Transfection Reagent and Equipment Market by Application
  • 6.1.4: Growth Opportunities for the Global Transfection Reagent and Equipment Market by End Use
  • 6.1.5: Growth Opportunities for the Global Transfection Reagent and Equipment Market by Region
• 6.2: Emerging Trends in the Global Transfection Reagent and Equipment Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Transfection Reagent and Equipment Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Transfection Reagent and Equipment Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: PromoCell
• 7.2: OriGene Technologies
• 7.3: Thermos Fisher Scientific
• 7.4: Merck
• 7.5: Bio-Rad Laboratories
• 7.6: Lonza
• 7.7: Qiagen N.V.
• 7.8: Mirus Bio
• 7.9: Promega Corporation
• 7.10: F. Hoffmann-La Roche